With new NIH funding, Najib El-Sayed is repurposing cancer-fighting inhibitors to block the metabolic “off-switch” Leishmania uses to hijack the immune system.
This year’s recipients were recognized for work spanning artificial intelligence, climate science, student mentorship, and interdisciplinary education.
The new approach marks individual cells with light, allowing researchers to link a cell’s genetic makeup to its response during stimulation and behavior.